MedTrace Logo

Drug Eluting Stent Zilver PTX vs Bare Metal Stent Zilver Flex

NCT05296031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2023-08-08

No results posted yet for this study

Summary

Randomized study comparing the results between drug-eluting stents and standard bare metal stents, when treating femoropopliteal lesions in patients with critical limb ischemia.

Conditions

  • Vascular Diseases

Interventions

DEVICE

Treatment with Zilver PTX Drug Eluting Stent (DES) in femoropopliteal lesions

Randomized trial comparing drug eluting stent Zilver PTX vs Bare metal stent Zilver Flex in critical limb ischemia and treatment of lesions in femoral and popliteal arteries

DEVICE

Treatment with Zilver Flex Bare Metal Stent (BMS) in femoropopliteal lesions

Randomized trial comparing drug eluting stent Zilver PTX vs Bare metal stent Zilver Flex in critical limb ischemia and treatment of lesions in femoral and popliteal arteries

Sponsors & Collaborators

  • Skane University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-01
Primary Completion
2017-08-31
Completion
2019-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05296031 on ClinicalTrials.gov